![Page 1: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/1.jpg)
THE EXPANDING REACH OF THE DESIGNER DRUG MOVEMENT IN 2011: CHALLENGES FOR FORENSIC TOXICOLOGY & CHEMISTRY
Barry K Logan PhD, DABFT, National Director Forensic Services, NMS LabsWillow Grove PA
![Page 2: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/2.jpg)
History and Context
![Page 3: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/3.jpg)
Designer Drugs1980’s-methylfentanyl, MPPP, MDMA, 1990’s, early 2000’sPMA, rise of methamphetamine1991 Publication of PiHKAL1997 Publication of TiHKAL“Combat Methamphetamine Epidemic Act of 2005”Growth of the InternetBeginnings of the “Research Chemicals” or “New Psychedelic” Movement.
![Page 4: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/4.jpg)
Designer Drugs1980’s-methylfentanyl, MPPP, MDMA, 1990’s, early 2000’sPMA, rise of methamphetamine1991 Publication of PiHKAL1997 Publication of TiHKAL“Combat Methamphetamine Epidemic Act of 2005”Growth of the InternetBeginnings of the “Research Chemicals” or “New Psychedelic” Movement.
![Page 5: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/5.jpg)
Designer Drugs1980’s-methylfentanyl, MPPP, MDMA, 1990’s, early 2000’sPMA, rise of methamphetamine1991 Publication of PiHKAL1997 Publication of TiHKAL“Combat Methamphetamine Epidemic Act of 2005”Growth of the InternetBeginnings of the “Research Chemicals” or “New Psychedelic” Movement.
![Page 6: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/6.jpg)
Designer Drugs1980’s-methylfentanyl, MPPP, MDMA, 1990’s, early 2000’sPMA, rise of methamphetamine1991 Publication of PiHKAL1997 Publication of TiHKAL“Combat Methamphetamine Epidemic Act of 2005”Growth of the InternetBeginnings of the “Research Chemicals” or “New Psychedelic” Movement.
1995
![Page 7: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/7.jpg)
Designer Drugs1980’s-methylfentanyl, MPPP, MDMA, 1990’s, early 2000’sPMA, rise of methamphetamine1991 Publication of PiHKAL1997 Publication of TiHKAL“Combat Methamphetamine Epidemic Act of 2005”Growth of the InternetBeginnings of the “Research Chemicals” or “New Psychedelic” Movement.
![Page 8: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/8.jpg)
Designer DrugsMid 2000’sNew tools for drug synthesisResearch Chemical Supply Industry2C-B, 2C-E, 2C-T-7AMT, DMT, 5-MeO-DiPT 2004 Operation Web TrypKhat, cathinone, methcathinone
![Page 9: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/9.jpg)
Designer Drugs2008-2011Benzylpiperazines (6+)BZP, TFMPP, m-CPPSynthetic Cannabinoids (200+)JWH series, AM Series, RCS Series-Keto amphetamines (30+)Ephedrone, mephedrone, methylone, methedrone…Phenethylamines (2C suite) (15+)2C-B, 2C-E, 2C-I, 2C-B, 2C-T-7,…Pyrrolidophenones (pyrovalerones) (20+)-PVP, MDPV, PPP,…
![Page 10: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/10.jpg)
Legal Status
![Page 11: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/11.jpg)
Legal StatusTitle 21 United States Code (USC) Controlled Substances ActSchedules drugs according to their medical use, liability for addiction, and potential for abuse. Schedule I includes:
“…the following hallucinogenic substances, or which contains any of their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.”
![Page 12: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/12.jpg)
Legal StatusSection 812. Schedule I (c) 17 compounds including:3,4-methylenedioxyamphetamine 3,4-methylenedioxymethamphetamine 5-methoxy-3,4-methylenedioxy amphetamine. 3,4,5-trimethoxy amphetamineDiethyltryptamineDimethyltryptamine. 4-methyl-2,5-diamethoxyamphetamine.
![Page 13: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/13.jpg)
Legal StatusTemporary Scheduling3/1/2011 – Synthetic CannabinoidsJWH-018JWH-073JWH-200CP47,497 (C7)CP47,497 (C8)10/21/2011 “Bath Salts”MDPVMephedroneMethylone
![Page 14: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/14.jpg)
Legal StatusFederal Analog Act (1986)The Federal Analogue Act defines an analog as a substance which is 'substantially similar' to a scheduled substance and has either an effect 'similar to or greater than' a controlled substance or is thought to have such an effect.
21 U.S.C. § 813
Mephedrone
Methcathinone
![Page 15: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/15.jpg)
Analogs? Yes!USA v Washam (2002) 312 F.3d 926, 930(i) 1,4-Butanediol and GHB are both linear compounds containing four carbons and that there is only one difference between the substances on one side of their molecules”, and (ii) that 1,4-B is metabolized into GHB by the body and so produces substantially similar physiological effects.
![Page 16: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/16.jpg)
Analogs? No!USA v. Damon S. Forbes et al. (1992) 806 F.Supp. 232
(i) AET is a primary amine while DMT and DET are tertiary amines, (ii) AET cannot be synthesized from either DMT or DET, and (iii) the hallucinogenic or stimulant effects of AET are not substantially similar to the effects of DMT or DET.
AET
DMT
DET
![Page 17: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/17.jpg)
Synthetic Cannabinoids Update
![Page 18: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/18.jpg)
Syn Canns Behavioral Effects
![Page 19: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/19.jpg)
Syn Canns and Lethality
![Page 20: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/20.jpg)
Syn Canns and Lethality
![Page 21: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/21.jpg)
Syn Canns Prevalence
NFLIS, Oct 2011
Calls to Poison Control Centers
![Page 22: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/22.jpg)
NMS Labs Blood Positivity Rates
US DEA Controls JWH-018, 073, 200 and CP,47,497
![Page 23: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/23.jpg)
NMS Blood Positivity Rates
August 2011-September 2011
JWH-018 JWH-073 JWH-250 AM-2201 RCS-4
Range (ng/mL) 0.10 – 26 0.93 – 1.7 0.11 – 6.5 0.13 – 10 0.25 – 1.8
Mean ± SD (ng/mL) 2.98 ± 6.69 1.32 ± 0.54 1.12 ± 1.7 2.36 ± 2.97 0.72 ± 0.64
Median (ng/mL) 0.36 1.3 0.67 0.69 0.49
% Positive 12.3 1.6 10.7 27.0 4.1
JWH-019 JWH-081 JWH-122 JWH-210 RCS-8
% Positive 4.9 7.4 40.2 19.7 0.8
Graf, Kacinko & Logan, SOFT, October, 2011
No positives for JWH-200, AM-694
![Page 24: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/24.jpg)
Synn Cann Toxicity
![Page 25: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/25.jpg)
Synn Cann Toxicity
Young AC, Schwarz E, Medina G, Obafemi A, Feng SY, Kane C, Kleinschmidt K.Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratoryconfirmation. Am J Emerg Med. 2011 Jul 28.
![Page 26: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/26.jpg)
Bath Salts Update
![Page 27: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/27.jpg)
Bath Salts and Depression
![Page 28: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/28.jpg)
Bath Salts Toxicity
![Page 29: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/29.jpg)
Bath Salts and Violence
![Page 30: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/30.jpg)
Bath Salts and Violence
![Page 31: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/31.jpg)
Cathinones/MDPV prevalence
NFLIS, Oct 2011
Calls to Poison Control Centers
![Page 32: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/32.jpg)
Cathinones/MDPV prevalence
NFLIS, Oct 2011
![Page 33: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/33.jpg)
Mephedrone Toxicity
![Page 34: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/34.jpg)
Mephedrone Toxicity
![Page 35: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/35.jpg)
Bath Salts Toxicity
![Page 36: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/36.jpg)
What to test for?
![Page 37: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/37.jpg)
Designer Drug Scope2009-2011
Peters FT, Martinez-Ramirez JA. Analytical toxicology of emerging drugs of abuse. Ther Drug Monit. 2010 Oct;32(5):532-9.
![Page 38: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/38.jpg)
Designer Drug Scope2009-2011
Wohlfarth A, Weinmann W. Bioanalysis of new designer drugs. Bioanalysis. 2010 May;2(5):965-79.
![Page 39: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/39.jpg)
2011 Synthetic CannabinoidsJWH-007JWH-015JWH-018JWH-018 methyl hexyl homologJWH-019JWH-073JWH-073 methyl butyl homologJWH-081JWH-122JWH-133JWH-175JWH-200JWH-201JWH-203JWH-210JWH-250JWH-251JWH-302JWH-398
CP 47, 497 (C7)CP 47,497 (C8) CP 55,940AM-694AM-1220AM-1241AM-2201AM-2233RCS-4RCS-8WIN 48,098 (Pravadoline)WIN 55,212-2WIN 55,212-3CB-25CB-52
HU-210HU-211HU-308HU-331JT-7770
![Page 40: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/40.jpg)
Priority Analytical TargetsDesigner Stimulants/Hallucinogens:
Federal Schedules:Mephedrone, MDPV, and Methylone
State Schedule (PA)4-Methoxymethcathinone4-Fluoromethcathinone3-Fluoromethcathinone 2C-C, 2C-D, 2C-E, 2C-H, 2C-I, 2C-N, 2C-P, 2C-T-2, 2C-T-4
![Page 41: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/41.jpg)
Priority Analytical TargetsSynthetic Cannabinoids:
Federal Schedules:HU-210, -211, JWH-018, -073, -200, CP47,497 (C7), (C8)
State ScheduleJWH-019, JWH-250
OtherJWH-120, -210, AM-2201, -694, RCS-4, - 8, JWH-081, WIN48,098
![Page 42: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/42.jpg)
Priority Analytical TargetsOthers:
2C-B-FLY, 2-Bromo-dragonfly Tryptamines (5-MeO-DALT, 5-MeODiPT, AMT, DMT) Mitragynine (Kratom) Mesembrine/mesembrenol/hordenine (Kanna) Phenazepam Next: Aminoindanes, Benzofurans, Classical Hallucinogens
PsilocinLSDSalvinorin A/BDextromethorphan
![Page 43: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/43.jpg)
Designer Drugs/Hallucinogens Criminalistics Panel Comprehensive Stimulants and Hallucinogens Panel, Test
(7210LI/S) • 2,5-Dimethoxy-4-chloroamphetamine• 2,5-dimethoxy-4-iodophenethylamine • 2,5-dimethoxy-4-n-propylthiophenethylamine • 3, 4-methylenedioxyethamphetamine• 3,4-Methylenedioxyamphetamine• 3,4-Methylenedioxymethamphetamine• 3-Trifluoromethylphenylpiperazine• 4-Bromo-2,5-Dimethoxyphenethylamine • 4-fluoroamphetamine• 4-Fluorocathinone• 4-methyl-N-ethylcathinone• …
![Page 44: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/44.jpg)
Designer Drugs/Hallucinogens Criminalistics Panel Comprehensive Stimulants and Hallucinogens Panel, Test
(7210LI/S) • N-hydroxy-3,4-methylenedioxyamphetamine• para-Chlorophenylpiperazine• Pentylone• Phencyclidine• Psilocin• Salvinorin A• Scopolamine• THC• Thujone
![Page 45: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/45.jpg)
Designer Drugs/Hallucinogens Toxicology LCTOF Panel Hallucinogens Screen - Expanded, Test (8755B/SP/U)
![Page 46: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/46.jpg)
Designer Drugs/Hallucinogens Toxicology LCMSMS Panel Mephedrone & MDPV Stimulants Designer Drug Test,
(2623B/SP/U)
• Mephedrone• MDPV• Methylone (coming soon)
![Page 47: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/47.jpg)
Choice of Matrix Cathinones, Phenethylamines,
Tryptamines, Pyrovalerones Blood/Urine – Parent Compound 10/100ng/mL Salvia Blood/Urine – Salvinorin A/B 0.1ng/mL Synthetic Cannabinoids Blood – Parent Compound 0.1 – 50ng/mL Urine – Metabolites 0.1 – 100ng/mL
Lack of available reference materials Lack of labeled internal standards
requires careful validation.
![Page 48: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/48.jpg)
Screening Immunoassay – Benzylpiperazines Trazodone, meta-chlorophenylpiperazine (an
hallucinogenic drug and trazodone metabolite), and the hallucinogen trifluoromethylphenylpiperazine cross-react with the EMIT®II ecstasy immunoassay in urine.
Logan BK, et al. J Anal Toxicol. 2010 Nov;34(9):587-9.
Development of a Novel Benzylpiperazine ELISA Assay for Urine and Blood.
Rodrigues* WC et al. SOFT/TIAFT 2011
![Page 49: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/49.jpg)
Analytical Technique Immunoassay – Phenethylamines Evaluation of commercial enzyme-linked immunosorbent
assays to identify psychedelic phenethylamines. Kerrigan S, et al. J Anal Toxicol. 2011;35(7):444-51.
![Page 50: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/50.jpg)
Analytical Technique Immunoassay – Synthetic Cannabinoids NMS Labs data No cross-reactivity of synthetic cannabinoids or metabolites
with Immunalysis Cannabinoids ELISA assay, or EMIT II Cannabinoids assay, at 10,000ng/mL
Development of New Polyclonal Antibodies for the Screening of JWH Synthetic Cannabinoids and Metabolites
Benchikh, ME et al. SOFT/TIAFT 2011
![Page 51: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/51.jpg)
JWH-018/073 Urine ELISA Immunoassay – Synthetic Cannabinoids Synthetic Cannabinoid Metabolites Screen, Urine Test
(9563U) September 20th, 2011 NMS Labs releases JWH-018 and JWH-
073 ELISA. Cross reacts with 4-OH-JWH-018, 5-OH-JWH-018, 4-OH-
JWH-073, 4-OH-JWH-073
Does not cross react with THC-COOH
Cutoff = 5 ng/mL
![Page 52: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/52.jpg)
Synthetic Cannabinoids Blood - Synthetic Cannabinoids Synthetic Cannabinoids, Blood (Forensic) Test (9560B)
JWH-018 JWH-073 JWH-019 JWH-250 JWH-081 JWH-122 JWH-200 AM-2201 AM-694 RCS-4 RCS-8 RCS-4
![Page 53: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/53.jpg)
Synthetic Cannabinoids Urine - Synthetic Cannabinoids Synthetic Cannabinoid Metabolites Screen - Expanded,
Urine (Forensic) Test (9562U) JWH-018 N-(4-hydroxypentyl) metabolite JWH-018 N-(5-hydroxypentyl) metabolite JWH-019 N-(5-hydroxyhexyl) metabolite JWH-073 N-(3-hydroxybutyl) metabolite JWH-073 N-(4-hydroxybutyl) metabolite JWH-250 N-(4-hydroxypentyl) metabolite* AM-2201 N-(4-hydroxypentyl) metabolite
OO
N
OH
![Page 54: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/54.jpg)
Analytical Technique GCMS
Good candidate for parent compounds Limited sensitivity in full scan Most information for structural discrimination of closely related compounds. Some synthetic cannabinoids and amphetamine compounds require derivatization.
CP47,497 (C7) DOM
![Page 55: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/55.jpg)
Analytical Technique LCMSMS
Superior sensitivity Limited fragmentation Shared transitions for close relatives Requires separation in time/good chromatography
N
O
OH
N
O
OH
OH
358 374
155 155
127 127
JWH-018 monohydroxy JWH-018 dihydroxy
![Page 56: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/56.jpg)
JWH-018 Metabolism
NMS Labs, June 2011
![Page 57: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/57.jpg)
JWH-018/073 Metabolism
![Page 58: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/58.jpg)
Analytical Technique High Resolution/LCTOF
Superior sensitivity Molecular formula identification Many pairs of isobaric compounds exist
HU-210/HU-211 3-fluoromethcathinone/4-fluoromethcathinone MDMA/3,4-BDB/p-MeO-MMA, etc JWH-007/JWH-019 JWH-122/180 JWH-049/JWH-182
Hudson et al. J Anal Toxicol. 2010 Jun;34(5):252-60.
![Page 59: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/59.jpg)
Summary Rapidly changing market. Regulation always a step behind the market.
Analog definitions will be fought out in court. Growing evidence of adverse effects.
Violence, paranoia, psychosis, possible cardiotoxicity, and unexplained deaths.
Laboratories should update their scope and keep it targeted to most prevalent compounds.
LCMSMS/LCTOF are the most versatile techniques for detecting biomarkers.
Innovative strategies required for identification of metabolites and acquisition of standards.
![Page 60: The Expanding Reach of the Designer Drug Movement in 2011: Challenges for Forensic Toxicology & Chemistry](https://reader034.vdocuments.net/reader034/viewer/2022042813/546c3fd7b4af9f8e2c8b50a5/html5/thumbnails/60.jpg)
ACKNOWLEDGEMENTS
Staff of NMS Labs
Criminalistics
Toxicological Services
Research and Development Department
LC-MS/MS Department
QUESTIONS?